The role of estrogens for male bone health.

Sex steroids are important for the growth and maintenance of both the female and the male skeleton. However, the relative contribution of androgens versus estrogens in the regulation of the male skeleton is unclear. Experiments using mice with inactivated sex steroid receptors demonstrated that both activation of the estrogen receptor (ER)alpha and activation of the androgen receptor result in a stimulatory effect on both the cortical and trabecular bone mass in males. ERbeta is of no importance for the skeleton in male mice while it modulates the ERalpha-action on bone in female mice. Previous in vitro studies suggest that the membrane G protein-coupled receptor GPR30 also might be a functional ER. Our in vivo analyses of GPR30-inactivated mice revealed no function of GPR30 for estrogen-mediated effects on bone mass but it is required for normal regulation of the growth plate and estrogen-mediated insulin-secretion. Recent clinical evidence suggests that a threshold exists for estrogen effects on bone in men: rates of bone loss and fracture risk seem to be the highest in men with estradiol levels below this threshold. Taken together, even though these findings do not exclude an important role for testosterone in male skeletal homeostasis, it is now well-established that estrogens are important regulators of bone health in men.

[1]  A. Meikle Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men , 2010 .

[2]  B. Olde,et al.  The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[3]  B. Olde,et al.  Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. , 2009, Endocrinology.

[4]  A. Silman,et al.  Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  D. Mellström,et al.  Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  E. Ghigo,et al.  A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. , 2008, Bone.

[7]  T. Travison,et al.  Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. , 2008, The Journal of clinical endocrinology and metabolism.

[8]  Tudor I. Oprea,et al.  GPR30: a novel therapeutic target in estrogen-related disease. , 2008, Trends in pharmacological sciences.

[9]  Tudor I. Oprea,et al.  Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. , 2008, Annual review of physiology.

[10]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[11]  J. Eisman,et al.  Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. , 2008, Archives of internal medicine.

[12]  A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study. , 2007, European journal of endocrinology.

[13]  D. Kiel,et al.  Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. , 2006, The American journal of medicine.

[14]  O. Johnell,et al.  Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  S. Boonen,et al.  Relative Impact of Androgen and Estrogen Receptor Activation in the Effects of Androgens on Trabecular and Cortical Bone in Growing Male Mice: A Study in the Androgen Receptor Knockout Mouse Model , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  S. Andò,et al.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.

[17]  D. Mellström,et al.  Polymorphisms in the Aromatase Gene Predict Areal BMD as a Result of Affected Cortical Bone Size: The GOOD Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  S. Andò,et al.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.

[19]  J. Kaufman,et al.  The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.

[20]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[21]  J. Dong,et al.  Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. , 2005, Endocrinology.

[22]  A. Hofman,et al.  Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  M. Brandi,et al.  A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. , 2004, The Journal of clinical endocrinology and metabolism.

[24]  E. Simpson,et al.  Role of CRE-Binding Protein (CREB) in Aromatase Expression in Breast Adipose , 2003, Breast Cancer Research and Treatment.

[25]  R. Nuti,et al.  Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. , 2003, The Journal of clinical endocrinology and metabolism.

[26]  J. Gustafsson,et al.  Differential effects on bone of estrogen receptor α and androgen receptor activation in orchidectomized adult male mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Kaufman,et al.  Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  R. Baron,et al.  A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. , 2003, The Journal of clinical investigation.

[29]  K. Dahlman-Wright,et al.  Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice , 2003 .

[30]  K. Dahlman-Wright,et al.  Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. , 2003, Molecular endocrinology.

[31]  K. Sjögren,et al.  Effects of Liver‐Derived Insulin‐Like Growth Factor I on Bone Metabolism in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[33]  K. Dahlman-Wright,et al.  Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. , 2002, The Journal of endocrinology.

[34]  Sundeep Khosla,et al.  Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.

[35]  B. Riggs,et al.  Estrogen and the Male Skeleton , 2002 .

[36]  S. Mohan,et al.  Two Different Pathways for the Maintenance of Trabecular Bone in Adult Male Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  R. Baron,et al.  Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. , 2002, Bone.

[38]  K. Bland,et al.  Estrogen Action Via the G Protein-Coupled Receptor , GPR 30 : Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis , 2001 .

[39]  J. Gustafsson,et al.  Estrogen receptor specificity in the regulation of the skeleton in female mice. , 2001, The Journal of endocrinology.

[40]  L. Melton,et al.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  S. Windahl,et al.  Female Estrogen Receptor β−/− Mice Are Partially Protected Against Age‐Related Trabecular Bone Loss , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  J. Clive,et al.  The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. , 2001, The Journal of clinical endocrinology and metabolism.

[43]  S. Boonen,et al.  Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. , 2000, Biochemical and biophysical research communications.

[44]  P. Delmas,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Bioavailable Estradiol May Be an Important Determinant of Osteoporosis in Men: The MINOS Study* , 2022 .

[45]  D. Kiel,et al.  Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study , 2000, Annals of Internal Medicine.

[46]  D. Grobbee,et al.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.

[47]  J. Gustafsson,et al.  Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  V. Rochira,et al.  Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. , 2000, The Journal of clinical endocrinology and metabolism.

[49]  D. Mühlen,et al.  Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. , 2000, The Journal of clinical endocrinology and metabolism.

[50]  J. Eisman,et al.  Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. , 1999, The Journal of clinical endocrinology and metabolism.

[51]  J. Gustafsson,et al.  Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.

[52]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Sjögren,et al.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Ohlsson,et al.  Expression and Localization of Estrogen Receptor‐β in Murine and Human Bone , 1999 .

[55]  C. Ohlsson,et al.  Expression and localization of estrogen receptor-beta in murine and human bone. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  C. Ohlsson,et al.  Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. , 1999, The Journal of clinical endocrinology and metabolism.

[57]  S. Chanprasertyothin,et al.  Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males , 1998, Clinical endocrinology.

[58]  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. , 1998, The New England journal of medicine.

[59]  G G Klee,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estroge , 2022 .

[60]  E. Barrett-Connor,et al.  Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[61]  C. Slemenda,et al.  Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. , 1997, The Journal of clinical investigation.

[62]  K. Korach,et al.  Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.

[63]  S. Boonen,et al.  Androgens and bone. , 2004, Calcified tissue international.

[64]  E. Simpson,et al.  Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.

[65]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.